Maravai (MRVI) director granted 46,293 restricted stock units
Rhea-AI Filing Summary
LUCIER GREGORY T reported acquisition or exercise transactions in this Form 4 filing.
Maravai LifeSciences Holdings director Gregory T. Lucier reported an amended Form 4 showing an equity award and updated holdings. He received 46,293 shares of Class A Common Stock in the form of restricted stock units granted on May 26, 2026 at a grant price of $0.00 per share, awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan.
These restricted stock units vest in full on the earlier of one year from the grant date or the date of the 2027 annual meeting of stockholders. Following this award, Lucier directly owns 201,416 shares of Class A Common Stock and has an additional 109,784 shares held indirectly through a family partnership. The filing is also being amended to correct the purchase price previously reported on a Form 4 filed the same date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 46,293 shares
Net Buy
2 txns
Insider
LUCIER GREGORY T
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 46,293 | $0.00 | $0.00 |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 201,416 shares (Direct);
Class A Common Stock — 109,784 shares (Indirect, By Family Partnership)
Footnotes (2)
- F1. Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.
- F2. This Form 4 is being amended to correct the purchase price previously reported on a Form 4 filed this date.
Key Figures
RSU grant size: 46,293 shares
Grant price: $0.00 per share
Direct holdings after award: 201,416 shares
+2 more
5 metrics
RSU grant size
46,293 shares
Restricted stock units granted on May 26, 2026
Grant price
$0.00 per share
Restricted stock unit award under 2020 Omnibus Incentive Plan
Direct holdings after award
201,416 shares
Class A Common Stock directly owned after transactions
Indirect holdings via family partnership
109,784 shares
Class A Common Stock held indirectly by family partnership
Vesting horizon
Earlier of 1 year or 2027 meeting
RSUs vest in full by earlier of one year from May 26, 2026 or 2027 annual meeting
Key Terms
restricted stock units, 2020 Omnibus Incentive Plan, annual meeting of stockholders, Form 4
4 terms
restricted stock units financial
"Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2020 Omnibus Incentive Plan financial
"restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026"
annual meeting of stockholders financial
"vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders"
Form 4 regulatory
"This Form 4 is being amended to correct the purchase price previously reported on a Form 4 filed this date"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did MRVI director Gregory T. Lucier report?
Gregory T. Lucier reported receiving an equity award of 46,293 restricted stock units of Maravai Class A Common Stock. The award was granted with a zero-dollar grant price under the company’s 2020 Omnibus Incentive Plan and is reflected in his updated share holdings.
What are the vesting terms of Lucier’s 46,293 restricted stock units in MRVI?
The 46,293 restricted stock units vest in full on the earlier of one year from the May 26, 2026 grant date or the date of Maravai’s 2027 annual meeting. This single-vesting schedule links the award to both time-based service and the company’s future shareholder meeting.
Why was this Maravai (MRVI) Form 4/A filed as an amendment?
The Form 4/A was filed to correct the purchase price previously reported on a Form 4 filed the same date. The amendment clarifies that the grant price for the 46,293 restricted stock units was $0.00 per share under the company’s equity incentive plan.
Is Gregory T. Lucier’s new MRVI award an open-market stock purchase?
No, the 46,293 shares represent a grant of restricted stock units, not an open-market purchase. The award was made under Maravai’s 2020 Omnibus Incentive Plan at a grant price of $0.00 per share as part of his compensation, subject to vesting conditions.